The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 21, 2023

Filed:

Jul. 10, 2018
Applicants:

Cornell University, Ithaca, NY (US);

Memorial Sloan-kettering Cancer Center, New York, NY (US);

Inventors:

Lewis C. Cantley, New York, NY (US);

Bryan Ngo, New York, NY (US);

Samuel F. Bakhoum, New York, NY (US);

Assignees:

Cornell University, Ithaca, NY (US);

Memorial Sloan-Kettering Cancer Center, New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6886 (2018.01); A61K 31/04 (2006.01); C12N 15/113 (2010.01); G01N 33/50 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); A61K 31/04 (2013.01); A61K 48/0066 (2013.01); C12N 15/113 (2013.01); G01N 33/5011 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/158 (2013.01); G01N 33/5005 (2013.01); G01N 2400/00 (2013.01);
Abstract

As described herein, chromosomal missegregations, chromosomal micronuclei, cytosolic DNA, and combinations thereof are indicative of metastatic cancer. Methods and compositions are described herein that are useful for detection and treatment of patients with chromosomal instabilities such as chromosomal missegregations, chromosomal micronuclei, cytosolic DNA, and combinations thereof. For example, some of the methods and compositions include use of kinesin-13 proteins such as Kif2b, MCAK/Kif2c, or KIF13A. The methods and compositions can also include inhibitors of STING, ENPP1, cGAS, NF-kB transcription factor p52, NF-kB transcription factor RelB, or any combination thereof. Methods are also described for identifying compounds that are effective for treatment of cancer, including metastatic cancer.


Find Patent Forward Citations

Loading…